DOI: 10.1002/ame2.12482
Stem cells in pulmonary hypertension:Current understanding and future challenges
Xiaoyi Hu1
Jinming Liu2
Xiao Song3
Ping Yuan2
1.Department of Cardio-Pulmonary Circulation,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai,China;Department of Respiratory Medicine,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University,Hangzhou,China2.Department of Cardio-Pulmonary Circulation,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai,China3.Department of Thoracic Surgery,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai,China
摘要：1|CURRENT KNOWLEDGE OF STEM CELLS IN PULMONARY HYPERTENSION(PH)
1.1|PH
Pulmonary hypertension(PH)is a clinical and pathophysiological syn-drome characterized by structural or functional changes in the pulmo-nary arteries caused by various heterogeneous diseases and different pathogenic mechanisms.This results in elevated pulmonary vascular resistance and increased pulmonary arterial pressure,eventually lead-ing to right heart failure and potentially death.
机标关键词：hypertensioncurrentfuturestemcellschallengespulmonaryunderstanding
论文发表日期：2024-12-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：3( 961-963 )
英文信息